Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase

Journal of Neuroscience

Volumn 22, Issue 23, 2002, Pages 10116-10122

  Monfort, Pilar ^a   Muñoz, María Dolores ^a   Kosenko, Elena ^a   Felipo, Vicente ^a,b  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b Laboratorio de Neurobiologia de Prince Felipe Research Centre   (Spain)

Author keywords

CGMP; CGMP dependent protein kinase; Long term potentiation; Nitric oxide; NMDA receptors; Phosphodiesterase; Soluble guanylate cyclase

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP PHOSPHODIESTERASE; GUANOSINE PHOSPHATE; GUANYLATE CYCLASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; ZAPRINAST;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; RAT;

EID: 0036895966     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-23-10116.2002     Document Type: Article

References (35)

1. Akers RF, Lovinger DM, Colley PA, Linden DJ, Routtenberg A (1986) Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science 231:587-589.
2. Arancio O, Kandel ER, Hawkins RD (1995) Activity-dependent long-term enhancement of transmitter release by presynaptic 3′, 5′-cyclic GMP in cultured hippocampal neurons. Nature 376:74-80.
3. Arancio O, Antonova I, Gambaryan S, Lohmann SM, Wood JS, Lawrence DS, Hawkins RD (2001) Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation. J Neurosci 21:143-149.
4. Baginski ES, Foá PP, Zak B (1974) Glucose-6-phosphatase. In: Methods of Enzymatic Analysis (Bergmeyer HU, ed), pp 876-880. Weinheim, Germany: Verlag Chemie Weinheim.
5. Beltman J, Sonnenburg WK, Beavo JA (1993) The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases. Mol Cell Biochem 127-128:239-253.
6. Blitzer RD, Wong T, Nouranifar R, Iyengar R, Landau EM (1995) Postsynaptic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron 15:1403-1414.
7. Böhme GA, Bon C, Stutzmann JM, Doble A, Blanchard JC (1991) Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol 199:379-381.
8. Boulton CL, Southam E, Garthwaite J (1995) Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69:699-703.
9. Chetkovich DM, Klann E, Sweatt JD (1993) Nitric oxide synthase-independent long-term potentiation in area CA1 of hippocampus. Neuroreport 4:919-922.
10. Corbin JD, Turko IV, Beasley A, Francis SH (2000) Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur J Biochem 267:2760-2767.
11. Doyle C, Hölscher C, Rowan MJ, Anwyl R (1996) The selective neuronal NO synthase inhibitor 7-nitroindazole blocks both long-term potentiation and depotentiation of field EPSPs in rat hippocampal CA1 in vivo. J Neurosci 16:418-424.
12. Haley JE, Malen PL, Chapman PF (1993) Nitric oxide synthase inhibitors block long term potentiation induced by weak but not strong tetanic stimulation at physiological brain temperatures in rat hippocampal slices. Neurosci Lett 160:85-88.
13. Hu GY, Hvalby O, Walaas SI, Albert KA, Skjeflo P, Andersen P, Greengard P (1987) Protein kinase C injection into hippocampal pyramidal cells elicits features of long term potentiation. Nature 328:426-429.
14. Keppler D, Kaiser W (1985) Guanosine-5-triphosphate, guanosine-5-diphosphate and guanosine-5′-monophosphate. In: Methods of Enzymatic Analysis (Bergmeyer HU, ed), pp 409-418. Weinheim, Germany: Verlag Chemie Weinheim.
15. Kleppisch T, Pfeifer A, Klatt P, Ruth P, Montkowski A, Fässler R, Hofmann F (1999) Long-term potentiation in the hippocampal CA1 region of mice lacking cGMP-dependent kinases is normal and susceptible to inhibition of nitric oxide synthase. J Neurosci 19:48-55.
16. Kuzmiski JB, MacVicar BA (2001) Cyclic nucleotide-gated channels contribute to the cholinergic plateau potential in hippocampal CA1 pyramidal neurons. J Neurosci 21:8707-8714.
17. López-Molina L, Boddeke H, Muller D (1993) Blockade of long-term potentiation and of NMDA receptors by the protein kinase C antagonist calphostin C. Arch Pharmacol 348:1-6.
18. Louis JC, Revel MO, Zwiller J (1993) Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells. Biochim Biophys Acta 1177:299-306.
19. Lovinger DM, Wong KL, Murakami K, Routtenberg A (1987) Protein kinase C inhibitors eliminate hippocampal long-term potentiation. Brain Res 436:177-183.
20. Lu Y, Kandel ER, Hawkins RD (1999) Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci 19:10250-10261.
21. Montoliu C, Llansola M, Kosenko E, Corbalán R, Felipo V (1999) Role of cyclic GMP in glutamate neurotoxicity in primary cultures of cerebellar neurons. Neuropharmacology 38:1883-1891.
22. Mufioz MD, Monfort P, Gaztelu JM, Felipo V (2000) Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro. Neurochem Res 25:437-441.
23. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O (1991) Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 88:11285-11289.
24. Santschi L, Reyes-Harde M, Stanton PK (1999) Chemically induced, activity-independent LTD elicited by simultaneous activation of PKG and inhibition of PKA. J Neurophysiol 82:1577-1589.
25. Schuman EM, Madison DV (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254:1503-1506.
26. Schuman EM, Meffert MK, Schulman H, Madison DV (1994) An ADP-ribosyl transferase as a potential target for nitric oxide action in hippocampal long-term potentiation. Proc Natl Acad Sci USA 91:11958-11962.
27. Selig DK, Segal MR, Liao D, Malenka R, Malinow R, Nicoll RA, Lisman JE (1996) Examination of the role of cGMP in long-term potentiation in the CA1 region of the hippocampus. Learn Mem 3:42-48.
28. Son H, Lu Y, Zhuo M, Arancio O, Kandel E, Hawkins R (1998) The specific role of cGMP in hippocampal LTP. Learn Mem 5:231-245.
29. Thomas MK, Francis SH, Corbin JD (1990) Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP. J Biol Chem 265:14971-14978.
30. Wu J, Wang Y, Rowan MJ, Anwyl R (1998) Evidence for involvement of the cGMP-protein kinase G signaling system in the induction of long-term depression, but not long-term potentiation, in the dentate gyrus in vitro. J Neurosci 18:3589-3596.
31. Wyatt TA, Naftilan AJ, Francis SH, Corbin JD (1998) ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am J Physiol 274:448-455.
32. Zhuo M, Hu Y, Schultz C, Kandel ER, Hawkins RD (1994) Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 368:635-639.
33. Zucker RS (1989) Short-term synaptic plasticity. Annu Rev Neurosci 12:13-31.
34. Zwiller J, Revel MO, Basset P (1981) Evidence for phosphorylation of rat brain guanylate cyclase by cyclic-AMP-dependent protein kinase. Biochem Biophys Res Commun 101:1381-1387.
35. Zwiller J, Revel MO, Malviya AN (1985) Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro. J Biol Chem 260:1350-1353.